Not available outside of the UK & Ireland.
Biochem/physiol Actions
Droperidol is a potent antagonist of dopamine subtype 2 receptor. It is an antipsychotic, which is used to treat acute behavioral anomalies. It helps to manage postoperative nausea and vomiting.
D1, D2 dopamine receptor antagonist; butyrophenone antipsychotic and anti-emetic.
Features and Benefits
This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This product has met the following criteria: